GENERIC DRUG TRENDS Generics "Pipeline" Predicts Continued Market Share Gains Through 2014

Buffery, Dalia
November 2010
American Health & Drug Benefits;Nov/Dec2010, Vol. 3 Issue 6, p391
Academic Journal
The article focuses on a forecast of increased marked share for generic drugs in the U.S. through 2014. It states a number of top-selling drugs including the statins Lipitor and Crestor and the gastrointestinal drug Nexium will have patents expire by 2014. It mentions the expiration of patent will reinforce the potential impact of generic drug markets and allow patient management to have greater access to generic medications. It comments on U.S. legislation concerning biosimilar medications.


Related Articles

  • "generic" BIOLOGICS. FOXHALL, KATHRYN // Arthritis Today;Nov/Dec2011, Vol. 25 Issue 6, p53 

    The article offers information on biosimilar drugs useful for the treatment of arthritis patients. It mentions about the substances used in the formation of biosimilars, and the cautions that are needed to be taken while consuming them. It states that with time the use of biosimilars among...

  • BIOSIMILARS: On pins and needles. Weinstein, Deborah // Medical Marketing & Media;Mar2013, Vol. 48 Issue 3, p40 

    The article offers the author's insights on the emergence of biosimilars and biologics in the U.S. pharmaceutical industry. She says that the shortfall of biosimilars market and the branded market in the country is that the biologics-biosimilars discount is not as wide as the one between...

  • Biosimilars could save $US billions.  // PharmacoEconomics & Outcomes News;Nov2014, Vol. 716 Issue 1, p1 

    The article discusses a report from nonprofit research institute Rand Corp., which examines the cost savings potential of biosimilars or generic versions of biologicals used in treating various medical conditions until 2024 in the U.S.

  • The pros and cons of generic drugs. Kamerow, Douglas // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/23/2011, Vol. 343 Issue 7816, p184 

    No abstract available.

  • Corrigendum: Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages.  // Clinical Pharmacology & Therapeutics;May2013, Vol. 93 Issue 5, p451 

    A correction to the article "Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages" that was published in the Match 20, 2013 issue is presented.

  • Generic prescribing is expected to save Spain €2bn a year. Rada, Aser García // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/30/2011, Vol. 343 Issue 7817, p228 

    The article informs that a medical law in Spain now requires that doctors should prescribe generic drugs wherever possible and it is expected that this strategy will save 2 billion euros a year for the health service.

  • Similar concerns. Daly, Rich // Modern Healthcare;7/11/2011, Vol. 41 Issue 28, p38 

    The article discusses the U.S. Food and Drug Administration's (FDA) regulatory approval process for biological medicines and their generic versions. The FDA started creating guidelines to determine the effectiveness and safety of the generic versions of biosimilars or protein-based drugs. An...

  • Palm Beach County, Fla.  // American City & County;Dec93, Vol. 108 Issue 13, p19 

    Reports on the savings derived by Palm Beach County, Florida taxpayers as a result of switching from brand name to generic drugs. County program to reduce costs and promote new revenues; Total annual savings; Combination of one-time savings and new revenues.

  • Biosimilars and the Patient Protection and Affordable Care Act: Where do we stand? Elias, Eve C. // Formulary;Nov2011, Vol. 46 Issue 11, p474 

    The recent passage of the Patient Protection and Affordable Care Act (PPACA) will generate unprecedented changes to the healthcare system of the United States. Among the long-awaited provisions in PPACA are the additions to the Public Health Service Act that allow for the introduction of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics